Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-17

Clinical Trial Update: Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease [NA]

View source ↗

Summary

A clinical trial update evaluating modified anti-tubercular regimens for tuberculosis in patients with chronic liver disease (compensated and decompensated), fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Chronic Liver Disease With Tuberclosis | NA | Status: UNKNOWN